CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- 4 Open-market buy Director bought 4,200 shares at $0.89 ($3,738)
- 4/A Open-market buy Interim CEO bought 5,000 shares at $0.89 ($4,450)
- 4 Open-market buy Acting COO bought 5,000 shares at an average $0.90 ($4,500)
- 4 Open-market buy Interim CEO bought 5,000 shares at $0.89 ($4,450)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- S-8 POS Other Post-effective Amendment
- 8-K Event Executive or director change · Other events
- 4 Open-market buy EVP Operations & Secretary bought 3,500 shares at $1.21 ($4,235)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change · Bylaws or fiscal year change
- S-8 Other Securities Offered to Employees in Benefit Plans
- AW Other AW
- AW Other AW
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 4 Open-market buy Director bought 9,000 shares at an average $2.43 ($21,900)
Page 46 of 58 · 1,148 filings